First human test of Triple-Threat vaccine targets common respiratory viruses
⭐️ VACCINE ⭐️
Recruiting now
This early-stage study is testing a new combined vaccine designed to protect older adults against three common viruses that cause respiratory infections: RSV, hMPV, and PIV3. Researchers will give 240 healthy participants aged 60-83 either the experimental vaccine, comparison vac…
Phase: PHASE1 • Sponsor: Vicebio Australia Proprietary Limited • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 30, 2026 14:29 UTC